Abstract:To identify protein biomarkers capable of early prediction regarding the distinguishing malignant pleural effusion (MPE) from benign pleural effusion (BPE) in patients with lung disease. A four-dimensional data independent acquisition (4D-DIA) proteomic was performed to determine the differentially expressed proteins in samples from 20 lung adenocarcinoma MPE and 30 BPE. The significantly differential expressed proteins were selected for Gene Ontology (GO) enrichment and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis. Protein biomarkers with high capability to discriminate MPE from BPE patients were identified by Random Forest (RF) algorithm prediction model, whose diagnostic and prognostic efficacy in primary tumors were further explored in public datasets, and were validated by ELISA experiment. 50 important proteins (30 up-regulated and 20 down-regulated) were selected out as potential markers to distinguish the MPE from BPE group. GO analysis revealed that those proteins involving the most important cell component is extracellular space. KEGG analysis identified the involvement of cellular adhesion molecules pathway. Furthermore, the Area Under Curve (AUC) of these proteins were ranged from 0.717 to 1.000,with excellent diagnostic properties to distinguish the MPE. Finally, significant survival and gene and protein expression analysis demonstrated BPIFB1, DPP4, HPRT1 and ABI3BP had high discriminating values. Significance We performed a 4D-DIA proteomics to determine the differentially expressed proteins in pleural effusion samples from MPE and BPE. Some potential protein biomarkers were identified to distinguish the MPE from BPE patients., which may provide helpful diagnostic and therapeutic insights for lung cancer. This is significant because the median survival time of patients with MPE is usually 4–12 months, thus, it is particularly important to diagnose MPE early to start treatments promptly. The most common causes of MPE are lung cancers, while pneumonia and tuberculosis are the main causes of BPE. If more diagnostic markers could be identified periodically, there would be an important significance to clinical diagnose and treatment with drugs in lung cancer patients.

DNA content,the expression of VEGF and p53 in pleural effusion can predict the cure and prognosis

The study of pleural lavage cytology for lung cancer

The expression levels of VEGF and ICAM-1 in pleural effusion

Correlation Between the Expression of P53v, P16 Gene and DNA Content in the Tumor Tissue of Patients with Lung Cancer and Its Significance

Effect of bevacizumab on angiogenesis and related cytokines in mice with malignant pleural effusion

Expression and Correlations of Survivin、VEGF and P53 in Lung Squamous Cell Cacinomas and Adenocarcinomas

Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.

Pd-L1 Expression Indicates Favorable Prognosis for Advanced Lung Adenocarcinoma Patients Treated with Pemetrexed

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

Genome-wide Microrna Expression Profiling in Malignant Pleural Effusion to Identify a Ten-Microrna Signature.

Correlative Studies Between DNA Content and Metastasis Associate Gene Expression in Patient with Non-Small Cell Lung Canner

Clinical Characteristics and Prognostic Factors in Breast Cancer with Malignant Pleural Effusion

Expression and Clinical Significance of Survivin and Its Correlation with P53 in Lung Squamous Cell Cacinomas and Adenocarcinomas

[A Method for Isolating Tumor Cells from Large Volume of Malignant Pleural  Effusion and Its Efficacy Evaluation].

Correlation Between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes

Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion

Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis

Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer

A study of pleural effusion in genomic detection of lung adenocarcinoma

[The Study of Pleural Effusion Supernatant Cell-Free Tumor DNA in Tumor Mutational Burden Assessment of Advanced Lung Cancer].

Positive Expression of P53, C-Erbb2 and MRP Proteins is Correlated with Survival Rates of NSCLC Patients.